| Product Code: ETC9514298 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname import shipments of intravenous antibodies show a shift in concentration towards key exporting countries like Peru, Netherlands, USA, Brazil, and Germany in 2024. The Herfindahl-Hirschman Index (HHI) indicates a significant increase in market concentration, reflecting the dominance of these countries in supplying intravenous antibodies to Suriname. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) of 2.08% over the period 2020-24 suggests steady expansion in the market. This trend highlights the importance of these top exporting countries in meeting Suriname demand for intravenous antibodies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Intravenous Antibodies Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Intravenous Antibodies Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Intravenous Antibodies Market - Industry Life Cycle |
3.4 Suriname Intravenous Antibodies Market - Porter's Five Forces |
3.5 Suriname Intravenous Antibodies Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Suriname Intravenous Antibodies Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Suriname Intravenous Antibodies Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Suriname Intravenous Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Intravenous Antibodies Market Trends |
6 Suriname Intravenous Antibodies Market, By Types |
6.1 Suriname Intravenous Antibodies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Suriname Intravenous Antibodies Market Revenues & Volume, By IgG, 2022 - 2032F |
6.1.4 Suriname Intravenous Antibodies Market Revenues & Volume, By IgA, 2022 - 2032F |
6.1.5 Suriname Intravenous Antibodies Market Revenues & Volume, By IgM, 2022 - 2032F |
6.1.6 Suriname Intravenous Antibodies Market Revenues & Volume, By IgE, 2022 - 2032F |
6.1.7 Suriname Intravenous Antibodies Market Revenues & Volume, By IgD, 2022 - 2032F |
6.2 Suriname Intravenous Antibodies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Immunodeficiency Diseases, 2022 - 2032F |
6.2.3 Suriname Intravenous Antibodies Market Revenues & Volume, By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), 2022 - 2032F |
6.2.4 Suriname Intravenous Antibodies Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura, 2022 - 2032F |
6.2.5 Suriname Intravenous Antibodies Market Revenues & Volume, By Hypogammaglobulinemia, 2022 - 2032F |
6.2.6 Suriname Intravenous Antibodies Market Revenues & Volume, By Myasthenia Gravis, 2022 - 2032F |
6.2.7 Suriname Intravenous Antibodies Market Revenues & Volume, By Multifocal Motor Neuropathy, 2022 - 2032F |
6.2.8 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2022 - 2032F |
6.2.9 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Suriname Intravenous Antibodies Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Intravenous Antibodies Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 Suriname Intravenous Antibodies Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 Suriname Intravenous Antibodies Market Revenues & Volume, By Others, 2022 - 2032F |
7 Suriname Intravenous Antibodies Market Import-Export Trade Statistics |
7.1 Suriname Intravenous Antibodies Market Export to Major Countries |
7.2 Suriname Intravenous Antibodies Market Imports from Major Countries |
8 Suriname Intravenous Antibodies Market Key Performance Indicators |
9 Suriname Intravenous Antibodies Market - Opportunity Assessment |
9.1 Suriname Intravenous Antibodies Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Suriname Intravenous Antibodies Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Suriname Intravenous Antibodies Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Suriname Intravenous Antibodies Market - Competitive Landscape |
10.1 Suriname Intravenous Antibodies Market Revenue Share, By Companies, 2025 |
10.2 Suriname Intravenous Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here